FFA
PLSE icon

Farther Finance Advisors’s Pulse Biosciences PLSE Stock Holding History

Farther Finance Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
13,094
+934
+8% +$22K ﹤0.01% 1795
2026
Q1 		$280K Sell
12,160
-8,213
-40% -$152K ﹤0.01% 1777
2025
Q4 		$280K Buy
20,373
+5,734
+39% +$89.4K ﹤0.01% 1688
2025
Q3 		$259K Buy
14,639
+6,050
+70% +$95.7K ﹤0.01% 1463
2025
Q2 		$130K Sell
8,589
-409
-5% -$6.79K ﹤0.01% 1623
2025
Q1 		$143K Buy
8,998
+1,778
+25% +$33.1K ﹤0.01% 1368
2024
Q4 		$126K Buy
7,220
+2,220
+44% +$39.1K ﹤0.01% 1212
2024
Q3 		$87.7K Hold
5,000
– – ﹤0.01% 1367
2024
Q2 		$54.1K Sell
5,000
-3,000
-38% -$28.3K ﹤0.01% 1386
2024
Q1 		$63.9K Buy
+8,000
New +$73.5K ﹤0.01% 1097

Other funds holding PLSE

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
CFS
CGC Financial Services Lake Oswego, Oregon $445M AUM 17.73% 1-Year Est. Return

Farther Finance Advisors's PLSE Position: Q2 2026 in Review

Farther Finance Advisors increased its Pulse Biosciences (PLSE) stake by 7.7% in Q2 2026, buying an estimated $22K and bringing the position to 13,094 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Farther Finance Advisors first reported a position in PLSE in Q1 2024 and has held it in 10 quarters since. 4 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Farther Finance Advisors held 13,094 shares of Pulse Biosciences worth $363K as of Q2 2026.
  • Farther Finance Advisors bought 934 Pulse Biosciences shares in Q2 2026, an estimated $22K.
  • Pulse Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1795 holding.
  • Farther Finance Advisors first reported a position in Pulse Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 4 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.